Table 1.
Clinical and demographic characteristics of HIV-infected individuals with T1MI vs. T2MI
| Characteristic | T1MI* N=362 N (%) |
T2MI N=288 N (%) |
P-value |
|---|---|---|---|
|
| |||
| Sex | 0.006 | ||
|
| |||
| Male | 293 (81) | 207 (72) | |
| Female | 69 (19) | 81 (28) | |
|
| |||
| Age, years | 0.01 | ||
|
| |||
| <40 | 32 (9) | 47 (16) | |
| 40–49 | 152 (42) | 106 (37) | |
| 50–59 | 125 (35) | 99 (34) | |
| 60–69 | 43 (12) | 22 (8) | |
| ≥70 | 10 (3) | 14 (5) | |
|
| |||
| Race/Ethnicity | <0.001 | ||
|
| |||
| White | 171 (47) | 65 (23) | |
| African-American | 156 (43) | 202 (70) | |
| Hispanic | 19 (5) | 14 (5) | |
| Other/unknown | 16 (4) | 7 (2) | |
|
| |||
| HIV Transmission Risk Factor | <0.001 | ||
|
| |||
| Heterosexual | 101 (28) | 93 (32) | |
| Men who have sex with men | 166 (46) | 75 (26) | |
| Injection drug use | 78 (22) | 107 (37) | |
| Other/unknown | 17 (5) | 13 (5) | |
|
| |||
| Antiretroviral therapy | <0.001 | ||
|
| |||
| Yes | 271 (75) | 154 (53) | |
| No | 91 (25) | 134 (47) | |
|
| |||
| CD4 count closest to event (cells/μl) | <0.001 | ||
|
| |||
| 0–200 | 94 (26) | 128 (44) | |
| 201–350 | 72 (20) | 57 (20) | |
| >350 | 195 (54) | 103 (36) | |
|
| |||
| CD4 cell count nadir (cells/μl) | 0.02 | ||
|
| |||
| 0–200 | 212 (59) | 199 (69) | |
| 201–350 | 79 (22) | 48 (17) | |
| >350 | 70 (19) | 41 (14) | |
|
| |||
| HIV-1 RNA closest to event | <0.001 | ||
|
| |||
| <400 | 217 (60) | 127 (44) | |
| 400–10,000 | 47 (13) | 49 (17) | |
| 10,000–100,000 | 63 (17) | 59 (20) | |
| >100,000 | 34 (9) | 53 (18) | |
|
| |||
| HIV-1 RNA, peak | 0.02 | ||
|
| |||
| <400 | 43 (12) | 20 (7) | |
| 400–10,000 | 35 (10) | 31 (11) | |
| 10,000–100,000 | 112 (31) | 70 (24) | |
| >100,000 | 171 (47) | 167 (58) | |
*
T1MI also includes patients with coronary interventions
One patient was missing CD4 and VL data prior to the MI and was excluded from those rows